Improving Anticoagulation Control in VISN 1

Completed · Not applicable

Conditions studied: Anticoagulants, Atrial Fibrillation, Venous Thromboembolism

In brief

Over 100,000 VHA patients receive anticoagulants (blood thinners) each year to prevent blood clots (including strokes). Too much anticoagulation increases the risk of serious or even fatal bleeding, and too little anticoagulation fails to protect the patient against blood clots. VHA anticoagulation clinics vary widely on how much time their patients spend in the therapeutic range, the range within which they are protected from clots but not at excessive risk of bleeding. Anticoagulation clinics can improve anticoagulation control by following several relatively simple procedures, including following-up promptly when patients are out of range and focusing on educating and supporting patients with poor control. In this study, the investigators will promote these practices at the anticoagulation clinics of the New England VA region, with a goal of improving anticoagulation control.

Key facts

Study ID

NCT01653405

Run by

VA Office of Research and Development

People needed

1260576

Starts

2014-10-01

Expected to finish

2016-09-30

Last updated by the study team

2019-04-16

Who can join

Age: 21 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• All patients receiving long-term oral anticoagulation with warfarin within the VA New England Region ("VISN 1")

You may not qualify if…

• Patients with valvular heart disease, who may have an INR target range other than 2-3. This usually represents between 10-15% of patients receiving anticoagulation.

Where it is running

• Edith Nourse Rogers Memorial Veterans Hospital, Bedford, MA — Bedford, Massachusetts, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.